NBC Securities’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.1K Sell
229
-50
-18% -$5.39K ﹤0.01% 1350
2026
Q2
$19.5K Sell
279
-214
-43% -$11.1K ﹤0.01% 1663
2026
Q1
$25K Sell
493
-49
-9% -$2.29K ﹤0.01% 1619
2025
Q4
$16K Buy
542
+75
+16% +$2.04K ﹤0.01% 1859
2025
Q3
$12.1K Buy
467
+311
+199% +$8.68K ﹤0.01% 1953
2025
Q2
$4K Buy
156
+1
+0.6% +$26 ﹤0.01% 2164
2025
Q1
$4K Buy
+155
New +$5.5K ﹤0.01% 1923
2024
Q4
– Sell
-577
Closed -$38K – 1776
2024
Q3
$38K Sell
577
-24
-4% -$2.2K ﹤0.01% 1256
2024
Q2
$71K Sell
601
-553
-48% -$70K 0.01% 1039
2024
Q1
$122K Sell
1,154
-68
-6% -$6.85K 0.01% 896
2023
Q4
$121K Buy
1,222
+205
+20% +$17.2K 0.01% 891
2023
Q3
$105K Buy
+1,017
New +$113K 0.01% 920

Other funds holding MRNA

NBC Securities's MRNA Position: Q3 2026 in Review

NBC Securities reduced its Moderna (MRNA) stake by 18% in Q3 2026, selling an estimated $5.39K and leaving 229 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.

NBC Securities first reported a position in MRNA in Q3 2023 and has held it in 12 quarters since. The position peaked at $122K in Q1 2024. 1,034 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • NBC Securities held 229 shares of Moderna worth $44.1K as of Q3 2026.
  • NBC Securities sold 50 Moderna shares in Q3 2026, an estimated $5.39K.
  • Moderna made up ﹤0.01% of NBC Securities's portfolio in Q3 2026, its #1350 holding.
  • NBC Securities first reported a position in Moderna in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Moderna position peaked at $122K in Q1 2024.
  • 1,034 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.